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Purpose: Head and neck cancer (HNC) diagnosis and treatment are distressing and have 
immediate detrimental impacts on functioning and quality of life (QoL). Nevertheless, little is 
known about long-term psychosocial effects. The aim of this study was to determine the 
prevalence and correlates of clinical post-traumatic stress disorder (PTSD) and subclinical 
post-traumatic stress symptoms (PTSS) in HNC patients surviving more than 2 years since 
treatment and in their partners.  
Methods: HNC survivors identified from the cancer registry of a London hospital and their 
partners completed measures of PTSS, depression and anxiety, fear of cancer recurrence, 
social support, appearance concerns and health-related QoL. Data regarding their clinical and 
demographic characteristics were also collected. Correlations, as well as linear and logistic 
regression coefficients, were calculated to estimate associations with PTSS scores.  
Results: In this analysis of 93 HNC survivors, at a mean of 6 years (SD=4) after treatment, 
33.4% reported PTSS and 11.8% met criteria for post-traumatic stress disorder (PTSD). Fear 
of cancer recurrence was independently associated with PTSS (p<.01). In subgroup analyses 
of patient-partner dyads 15.4% of patients and 12.8% of partners reported PTSD, with a 
further 33.3% of patients and 25.7% of partners demonstrating PTSS. Patients’ and partners’ 
scores did not differ significantly (p >.05).  
Conclusions: This is the first examination of post-traumatic stress in survivors of HNC and 
shows that high levels of cancer-related PTSS exist for many years after diagnosis in both 
patients and their partners.  
 









Head and Neck Cancer (HNC) is currently the sixth most common cancer worldwide
[1,2]
 with 
a steadily increasing incidence
[3]
. Five-year survival rates have risen to around 50% with an 
increase of cases related to human papillomavirus (HPV) infection. HPV-positive HNC 
patients are much younger and have a better prognosis 
[4,5]
. Thus, there are more HNC 
survivors facing long-term sequelae of HNC treatment. HNC is now better viewed as a 
chronic disease making quality of life (QoL) and overall wellbeing as treatment outcomes 
highly relevant. Depending on the site, HNC can significantly impact eating, drinking, 




The focus of HNC studies has been more on the potential demographic, functional and 
clinical characteristics associated with survivorship and QoL
[8]
, whereas psychosocial factors, 
particularly depression and anxiety, are the factors most strongly associated with poorer 
QoL
[9]
. In survivors (i.e. those who have completed their primary treatment for HNC), 
prevalence rates for clinically significant symptoms of depression and anxiety are reported as 
19-31% and 16% respectively 
[10,9]
. Caregivers of HNC patients are also at risk for 
psychological distress and previous studies have suggested that caregivers may suffer equal 
or even higher levels of distress than patients
[11,12]
. A diagnosis of HNC places a significant 
burden on the patients’ carers[11], but less is known about the specific issues they face. 
HNC treatment can be intrusive resulting in permanent functional and disfiguring changes, 
thereby increasing the likelihood of a post-traumatic stress reaction. Despite the potentially 
highly traumatic nature of HNC
[13]
, the prevalence of post-traumatic stress symptoms (PTSS) 
and post-traumatic stress disorder (PTSD) in long-term HNC survivors has not been 
investigated. PTSD is a psychiatric condition that affects some people when they have 
witnessed or experienced a traumatic event involving the risk of serious injury or death 
[14]
. 
Symptoms such as flashbacks, avoiding cancer-related experiences, and increased anxiety, 
have been reported in other cancer survivor groups with PTSD prevalence rates of 5-17%
[15-
18]
.  In newly diagnosed HNC patients, 12% of patients and 29% of partners met criteria for 
PTSD caseness
[19]
. Richardson and colleagues (2016) found that 19% of HNC patients [20] 
and their caregivers [21] met criteria for PTSD six months after treatment. To the best of the 
authors’ knowledge there have been no studies investigating whether cancer-related PTSS 
exist in long-term HNC survivors and in their partners. Therefore, the purpose of this study 
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was to (i) estimate the prevalence of PTSS in a cohort of British HNC survivors, (ii) identify 
potential demographic, clinical and psychosocial correlates of PTSS and (iii) compare PTSS 





Prospective participants were identified through the cancer registry at Barts Health NHS 
Trust. Eligible patients were those who had received a diagnosis of HNC, had completed 
active treatment (i.e. were in the follow-up phase), and were ≥2 years after diagnosis. 
Potential participants were sent an invitation letter asking whether they would be willing for 
the research team to invite their spouse to the study.  
The study questionnaire along with the information sheet and consent forms were mailed to 
those interested in participating. Patients and their partners were provided with separate 
postage-paid return envelopes. No financial incentives or any other forms of compensation 
were used. Ethics approval was obtained from the Office for Research Ethics Committees 
Northern Ireland (ORECNI)  (Reference: 15/NI/0009). 
Measures 
Demographic and clinical variables 
Sociodemographic information sought included gender, ethnicity, education, marital status, 
and work status. Clinical variables included cancer site and stage, treatment type, time since 
treatment and whether there had been a recurrence. Medical comorbidity was measured using 
the Self-Administered Comorbidity Questionnaire (SCQ)[22].Participants’ self-reported 
history of anxiety or depression preceding their HNC diagnosis were also evaluated.  
Psychosocial Variables and QoL  
The Hospital Anxiety and Depression Scale (HADS)
[23]





was selected to assess participants’ levels of psychological distress. This 
instrument consists of two subscales: 7 items assessing levels of depressive symptoms and 7 
items for levels of anxiety. Higher scores (range = 0-21) indicate increased distress. Social 
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support (SS) was measured using the ENRICHD Social Support Inventory (ESSI)
[25]
, a 
reliable 7-item scale previously used in cancer patients
[26]
. A total score can be produced by 
summation, with greater scores representing greater social support. Fear of cancer recurrence 
(FoR) was assessed using a 7-item questionnaire measuring worries associated with the risk 
of cancer coming back and their impact on daily life
[27]
. This instrument has been previously 
used in HNC patients
[28]
. Scores range from 6-40 with higher scores representing greater 
FoR. The Assessment of Life Threat and Treatment Intensity (ALTTIQ)
[29]
 is a 7-item 
questionnaire used to examine how threatening and intense patients perceive cancer and its 
treatment to be
[17,30]
. Responses are summed and scores range from 7-35. The Global QoL 
scale of the EORTC QLQ-C30 Version 3
[31]
 was used as the main QoL outcome. Responses 
are transformed to fit a 0-100 distribution. The QLQ-C30 has been extensively used in 
studies of HNC patients 
[32]
. Finally, the Derriford Appearance Scale (DAS24)
[33]
 was used to 
measure levels of appearance concerns. The total score ranges from 11 to 96, with lower 
scores reflecting low levels of social anxiety and avoidant behaviour. 
Post-traumatic Stress 
The PTSD Checklist-Civilian Version (PCL-C)
[34]
 is a validated 17-item self-report scale 
assessing the severity of traumatic stress symptoms
[35]
. Responses range from 1 “Not at all” 
to 5 “Extremely” and a total score (range =17-85) can be obtained by summation. Scores ≥44 
are classified as indicative of PTSD for adults who have experienced acute trauma
 [36]
. The 
PCL reflects the DSM-IV (Diagnostic and Statistical Manual of Mental Disorders – Fourth 
Edition) symptoms of PTSD. Using the cluster scoring method, a predefined level of 
symptoms in each symptom cluster (i.e. intrusive thoughts, avoidant behaviour, hyperarousal)  
needs to be endorsed in order for the scores to indicate PTSD
[19]
. Meeting the threshold in 
two symptom clusters indicates partial PTSD (i.e. PTSS)
[17]
. Questions were modified to 
reflect cancer and its treatment as the traumatic stressor of interest.  
Statistical Methods 
In bivariate analyses, t-tests and analysis of variance (ANOVA) were used in order to 
compare mean levels of PCL-C scores. Pearson’s correlation coefficient was used to examine 
associations between continuous variables and the PCL-C. Potential correlates of PTSS were 
then assessed using multiple linear regression analyses with patients’ PCL-C score as the 
outcome variable. The association of the same variables with full or partial PTSD was 
assessed using binary logistic regression. A stepwise modelling approach was followed 
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whereby only variables that were significantly associated (p < .05) with PCL-C in bivariate 
analyses were included in multiple regression models. 
Regarding the dyadic data analyses, differences between patients’ and partners’ scores on the 
PCL-C, as well as on their depression and anxiety scores, were examined using paired t-tests 
and McNemar’s χ
2 
test, as appropriate. Mann Whitney U and Kruskal-Wallis H tests were 
used for comparisons within subgroups due to their small sample size. Correlation 
coefficients were calculated to examine the association between all continuous variables and 
participants’ PCL-C scores. Agreement between patients’ and partners’ levels of post-
traumatic stress was assessed using weighted Cohen’s Kappa. In addition, overall PCL-C 
scores in dyads were examined for absolute agreement using the two-way mixed-effects 
intraclass correlation coefficient (ICC). All data were coded and analysed using IBM SPSS 




As shown in the consort diagram (Figure 1), the final study sample consisted of 93 HNC 
survivors while the dyadic analysis was conducted on data from a subsample of 39 patient-
partner dyads. There was no time lag between patients’ and partners’ return of the completed 
questionnaire. Table 1 presents the sample characteristics. Patients’ mean (±SD) age at 
enrolment was 66 years (11) and the overall male to female ratio was 1:0.72. The majority of 
patients were White British (84.8%) and their education was at least of high school level. 
Sixty eight percent were partnered and 66% were not in paid employment. Patients were at a 
mean (±SD) of 6.3 years (4) after treatment and 56% of them had an oral cavity tumour. The 
majority had early stage cancer (i.e. stage one or two) (66%) and did not have a recurrence 
(83%). Eighty seven percent were treated with surgery either alone or with adjuvant chemo-
radiation. Fifteen percent reported a history of anxiety while 25.8% reported a history of 
depression.  
Prevalence of Post-traumatic Stress in HNC survivors and their partners 
In this sample of HNC survivors (N=93), the mean (±SD) PCL-C score was 28.2 (11.5). As 
shown in Table 2, 11.8% of patients scored ≥44 indicating the presence of PTSD. Based on 
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the cluster scoring method, 12.9% of patients met the criteria for estimated PTSD caseness. A 
further 10.8% rated two out of three PTSD symptom clusters as moderately to extremely 
reoccurring (i.e. ‘partial PTSD’). Overall, 46.3% met criteria for at least one PTSD symptom 
cluster. Across the symptom clusters, 33.3% met criteria for intrusion, 29% for hyperarousal, 
and 20.4% for avoidance. 
With regards to the prevalence of post-traumatic stress in the subsample of 39 patient-partner 
dyads, the mean (±SD) PCL-C score was 28.6 (10.4) for patients and 27.8 (12.5) for partners. 
Patients’ and partners’ PTSS scores were not significantly different (t(38) = .35, p = .731) 
and did not correlate with each other (r=.23, p=.15). Thirteen percent of patients and 15.4% 
of partners scored ≥44 indicating PTSD caseness.  
Using the cluster scoring method, 6/39 (15.4%) of patients and 5/39 (12.8%) of partners 
endorsed the threshold symptom level reflecting PTSD caseness. A further 15.4% of patients 
and 10.3% of partners rated two out of three PTSD symptom clusters as moderately to 
extremely reoccurring (partial PTSD). Overall, 48.7% of patients and 38.5% of partners met 
criteria for at least one PTSD symptom cluster. Both patients  and  carers  rated more highly  
symptoms  of  intrusion,  with  35.9%  and  33.3%  respectively  meeting  the  threshold.  
Patients  endorsed  more  symptoms  of  avoidance  (25.6%)  and  hyperarousal  (33.3%)  in  
comparison  to  their  partners  (12.8%  and  28.2%  respectively)  however  the  difference  
was  not  statistically  significant (Table 3). 
Concordance analysis for levels of post-traumatic stress (i.e. symptomatic in 3 symptom 
cluster, symptomatic in 2 symptom clusters, symptomatic in 1 symptom cluster and 
asymptomatic) between patients and their partners showed that the strength of agreement was 
poor (κw= .187, p= .127). Similarly, the ICC test showed little agreement between patients’ 
and partners’ overall PCL-C scores (ICC= .378,  95% CI (-.202 to .676),  F(38,38)= 1.59, p= 
.078). Dyads with male caregivers (n=13) appeared more congruent than dyads with female 
caregivers (n=26) however this did not reach statistical significance.   
  
Bivariate Associations with PTSS 
Table 1 presents the bivariate associations between patients’ total PCL-C scores and the 
variable categories of interest. There were no significant associations between clinical 
variables and levels of post-traumatic stress.  
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Among demographic variables, a negative PCL-C association was found for age at the time 
of completing the questionnaire. There were no other significant associations between 
demographic variables and PCL-C scores.  
Among psychosocial variables, there were significant PCL-C associations for FoR, symptoms 
of anxiety and depression, as well as for appearance concerns. Levels of perceived threat 
were also highly positively correlated with patients’ PCL-C scores. SS levels were not 
significantly associated with PCL-C scores. Finally, there was a large negative correlation 
between PCL-C scores and QoL.  
Multivariable Analyses 
Table 4 presents the results of the multiple linear regression analysis for patients’ PCL-C 
scores and the variables that were statistically significant in bivariate analyses (p <.05). 
Results of a binary logistic regression for full or partial PTSD and the same explanatory 
factors are also presented in Table 4. Although the full linear regression model accounted for 
73.4% of the variance in PCL-C scores (p < .001), FoR was the only independent correlate of 
PTSS. There was a favourable statistical trend (p <.1) for symptoms of anxiety, QoL and 
appearance concerns however these were not statistically significant (p>.05). In the logistic 
regression model, FoR was the only significant correlate of PTSS.  
Dyads Subsample: Bivariate Analyses 
Although we were underpowered to detect differences in PTSS levels between patients and 
their partners or to investigate interactions within subgroups of partners, we carried out 
bivariate analyses to identify any trends in the data. 
With regards to their background characteristics, patients’ and partners’ symptoms of 
depression and anxiety, as well as their SS levels did not differ significantly (anxiety, t(38)= 
1.17, p= .25; depression, t(38)= .04, p= .97; SS t(38) = 1.79, p = .082) and were not 
significantly associated with each other (anxiety, r= -.006, p= .97; depression, r= .23, p= .17; 
SS, r= .29 , p= .07). Furthermore, 10% of patients and 12.8% of partners reported previous 
anxiety while 23% of patients and 23% of partners reported previous depression. 
Regarding potential correlates of PTSS levels in partners, between the clinical variables, prior 
history of depression was associated with higher PCL-C scores (U = 64, p = <.05). Among 
demographics the only significant relationship was for gender (U = 52, p = <.01) indicating 
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that female partners (n=26) experienced more severe PTSS than their male counterparts 
(n=13).  
Among psychosocial variables, significant PCL-C relationships were found for symptoms of 
depression (r = .570, p = <.01), anxiety (r = .766, p = <.01) and levels of social support (r = -
.560, p = <.01).  
Regarding possible interactions between partners’ PCL-C scores and patients’ characteristics 
or vice versa, there was a statistically significant relationship between partners’ PCL-C scores 
and patients’ QoL (r = -.329, p = <.05). Patients’ PCL-C score was associated only with 
partners’ SS levels (r = -.445, p = <.01).  
 
CONCLUSIONS 
This is the first study to examine post-traumatic stress in long-term HNC survivors and their 
partners. In this sample of HNC survivors, 13% of patients met diagnostic criteria for PTSD, 
with an additional 33% experiencing some PTSS. This is a much higher prevalence in 
comparison to that of the general adult population in the UK (4.4%) 
[37]
 but similar to other 
cancer survivor populations such as haematological (8%) or breast (12%) cancer 
[17,16]
. Our 
findings are also comparable to those of Posluszny et al (2015)[19] who reported a 12% 
prevalence of PTSD in HNC patients approximately two months after diagnosis , though  
Richardson et al (2016)[20] in their study of HNC patients 6 months after treatment reported 
a higher rate of  19% . In our sample, mean time since treatment was 6 years suggesting that 
PTSS may persist for many years after diagnosis. In the context of the growing literature on 
PTSD/PTSS amongst HNC patients, longitudinal research is needed in order to understand 
better the duration and course of these symptoms.  
Results from our subgroup analyses showed that 15.4% of patients and 12.8% of partners 
reported PTSD. Scores from a further 33.3% of patients and 25.7% of partners were 
indicative of PTSS. These results are not in line with the findings of Posluszny et al (2015) 
who reported significantly higher levels of PTSD in partners than in patients. Nevertheless, 
Richardson’s findings suggested a similar prevalence rate between HNC patients and their 
caregivers [21,20].  Further research employing greater sample sizes is needed.  
Clinical correlates of PTSS and PTSD 
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In bivariate analysis, younger age was significantly associated with higher PTSS; consistent 
with findings from the PTSD literature 
[35]
. Younger survivors may face more financial and 
social challenges 
[17]
 and the emotional response of older HNC patients is more positive 
[38]
. It 
is striking that there was no significant effect of cancer stage, site or treatment. This is in 
agreement with previous findings 
[35,21]
 and emphasises that PTSS experienced by cancer 
survivors may not consequently be connected to the severity of cancer or to socio-
demographic factors. Contrary to previous findings, time since treatment was not associated 
with reduced PTSS 
[17,39]
. Although patients with previous depression and anxiety were at 
higher risk for psychological distress and PTSD, this did not have a significant impact on 
PTSS scores. Reports of PTSS are more likely to reflect difficulties in adjustment to 
cancer
[40]
. Medical comorbidity has been shown to be a risk factor for PTSS 
[17]
 however this 
was not replicated in our sample.  
FoR was the strongest correlate of post-traumatic stress. FoR is a common emotional 
response to cancer but differs from a psychopathological response that is characterised by 
features of avoidance and hyperarousal such as PTSD. Nevertheless, FoR, depending on its 
intensity, can be difficult to distinguish from anxiety and PTSS.  
QoL, anxiety and appearance concerns showed significant but weak trends consistent with 
previous research
[40]
. In our sample, mean patient QoL was very close to the 2014 European 
general population mean (±SD) of 75.7 (21.2)[41]. Other studies have reported a negative 
correlation between appearance concerns and depression
[42]
, however, our study is the first to 
present findings on the association with PTSS. As the face is difficult to avoid, facial 
disfigurement may be acting as a constant reminder and trigger of trauma.  
Survivors and their partners experienced similar levels of PTSS but they showed little 
agreement in their appraisals of post-traumatic stress symptoms. Trends in the data indicated 
that female partners, those with a history of depression and those with less SS showed higher 
PTSS. Higher PTSS in partners was also related to more depressive symptoms, anxiety and 
lower patient QoL. Although further investigation is needed in order to confirm these 
patterns, our findings are in line with previous research that suggests a proportion of HNC 
partners experience poorer psychological health in comparison to population norms and that 
caregivers are affected by patients’ well-being (and vice versa)
[11,12]
. Further study of the 
factors affecting patient-caregiver PTSS congruence is warranted as this may influence 




This study has some limitations, including the cross-sectional design, the small sample size 
and the inclusion of patients from one cancer centre. The cross-sectional design limits our 
ability to infer causal relationships or to draw conclusions about the duration of PTSS since 
diagnosis. Although the inclusion of partners is a strength, given how little we know about 
partners’ emotional response to HNC, our sample size was too small for sub-group analyses 
amongst patients or dyads. Our participants were recruited from a single centre, limiting the 
generalisability of our results. Furthermore, our sample consisted of predominantly white 
patients and the recurrence rate was low which may further affect the generalisability of our 
findings. Nevertheless, our results show levels slightly higher than those reported in other 
cancer survivor groups 
[17,35]
. Finally, the assessment of PTSS/PTSD in this study was based 
on the diagnostic criteria of DSM-IV. This is a limitation as there are notable changes to the 
PTSD criteria in DSM-V. Therefore relevancy of these finding to DSM-V is not known. 
However, our results add to the existing literature on the prevalence of cancer-related PTSD 
and allow a reliable comparison of PTSS/PTSD rates between HNC survivors and different 
patient groups, as well as between HNC survivors and newly diagnosed patients. 
In conclusion, we found that in some HNC patients, symptoms of cancer-related PTSD exist 
for many years and also affect caregivers. Clinicians and researchers need to be aware of this 
type of psychological response to HNC in survivors and take this into account when 
addressing the needs of patients and their partners. PTSD is a treatable condition and referral 
to psychological services should be considered. Psychological interventions to reduce PTSD 
symptoms in HNC patients have shown some effectiveness [43,44] but further research is 
required for the development of targeted interventions that can also be used at an earlier stage 
to prevent PTSS in cancer survivors. Our study has identified potentially modifiable factors 
that may play a role in the development of cancer-related PTSD – namely, fear of recurrence. 
Understanding the issues HNC survivors and their caregivers face will enable identification 
of those at highest risk of suffering from post-traumatic stress.  
 
Compliance with Ethical Standards 
Ethical Approval: All procedures performed in studies involving human participants were in 
accordance with the ethical standards of the institutional and/or national research committee 
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  -.249 .016 
Gender (n = 93)     .205 





 39 (41.9) 26.4 (10.4)   
Ethnicity (n = 92, missing = 1)     .694 
White British  78 (84.8) 28.2 (11.3)   
White Other  7 (7.6) 25.7 (9.1)   
Asian  5 (5.4) 32.6 (15.5)   
Black 
 
 2 (2.2) 33.5 (23.3)   
Education (n = 77, missing = 16)     .527
 
 
>High School  40 (51.9) 29.4 (11.3)   
≤High School 
 
 37 (48.1) 27.6 (12.5)   
Relationship Status (n = 92, 
missing = 1) 
    .186 
Partnered  63 (67.7) 29.3 (12.3)   
Non-partnered 
 
 29 (31.2) 26.2 (9.3)   
Work Status (n = 91, missing = 2)     .359
 
 
Employed  31 (34.1) 29.9 (12.2)   
Unemployed 
 
 60 (65.9) 27.6 
(11.2) 
  
Site (n = 93)     .158 
Oral Cavity  52 (55.9) 28.4 (12)   
Oropharynx  22 (23.7) 26.8 (8.2)   
Nasopharynx  4 (4.3) 34 (15.6)   
Nasal Cavity  5 (5.4) 21.8 (4.6)   
Salivary gland  2 (2.2) 27 (11.3)   
Hypopharynx  2 (2.2) 29 (2.8)   
Larynx  2 (2.2) 17.5 (.1)   
Unknown primary 
 
 4 (4.3) 42 (17.9)   
Stage (n = 87, missing = 6)     .640 
Tx (tumour cannot be 
evaluated) 
 7 (8) 34.3 (17.9)   
T1  23 (26.4) 28.6 (11)   
T2  34 (39.1) 26.7 (10)   
T3  10 (11.5) 28.1 (9.2)   
















Treatment (n = 93)     .957 
Surgery  32 (34.4) 28.9 (13.9)   
Surgery & Radiotherapy  23 (24.7) 27 (10)   
Chemotherapy & 
Radiotherapy 
 9 (9.7) 26.7 (3.4)   
Chemotherapy & 
Radiotherapy & Surgery 
 26 (28) 28.4 (11.6)   
Radiotherapy  2 (2.2) 31 (18.4)   
Other 
 
 1 (1.1) 36 (-)   
Time since Treatment, months  
(n = 84,  missing = 9) 
 
75 (48),  
24-165 
  -.039 .727 
Recurrence (n = 90, missing = 3)     .961 





 15 (16.7) 28.7 (11)   
Self-administered Comorbidity 
(possible range = 0-45)  
(n = 82, missing = 11) 
 
5 (3.6),  
0-18 
  .193 .083 
History of depression (n = 93)     .083 





 69 (74.2) 27 (11.5)   
History of anxiety (n = 92, 
missing = 1) 
    .140 
Yes  14 (15.2) 31 (14)   
No 
 
 78 (84.8) 27.7 (11.1)   
HADS Depression Score 





  .625 .000 
HADS Anxiety Score 





  .676 .000 
Social Support Score 







  -.144 .172 
Appearance Concerns Score  





















Quality of Life Score 






  -.516 .000 
Fear of Recurrence Score  






  .743 .000 
Appraisal of Life Threat and 
Treatment Intensity Score 





  .555 .000 
Abbreviations: PTSS, Post-Traumatic Stress Symptoms; PCL-C, Post-Traumatic Stress 
Disorder Checklist – Civilian Version; N, number of patients; SD, standard deviation 
 †  Pearson product-moment correlation coefficient 












Table 2  Prevalence of cancer-related post-traumatic stress in head and neck cancer 
survivors (N=93)  
PTSD Measure† 
 
Frequency (%) 95% Confidence 
Intervals 
PCL-C Score ≥ 44 
 
11 (11.8) 6.7 to 20 
Symptomatic in 3 Symptom Clusters 
 
12 (12.9) 7.5 to 21.2 
Symptomatic in 2 Symptom Clusters 
 
10 (10.8) 6 to 18.7 
Symptomatic in 1 Symptom Cluster 
 
21 (22.6) 15.3 to 32.1 
Non-symptomatic 
 
50 (53.8) 43.7 to 63.6 
Met Cluster B (intrusion) criteria 
 
31 (33.3) 24.6 to 43.4 
Met Cluster C (avoidance) criteria 
 
19 (20.4) 13.5 to 29.7 
Met Cluster D (hyperarousal) criteria 27 (29) 20.8 to 38.9 
Abbreviations: HNC, Head and Neck Cancer; PTSD, Post-Traumatic Stress Disorder 
† As measured with the PTSD Checklist – Civilian Version (PCL-C). Symptom clusters 
include at least one intrusion symptom, three avoidance symptoms and two hyperarousal 











Table 4 Multiple Linear Regression for survivors’ PCL-C Score and Logistic 
Regression for Meeting Symptom Criteria for Full or Partial PTSD (N=78) 
 










Age at questionnaire 
completion 
-.05 -.18 to 
.08 
.467  .98 .91 to 
1.05 
.533 
HADS Anxiety Score .53 -.04 to 
1.10 





.36 -.33 to 
1.05 
.304  1.12 .83 to 
1.51 
.468 
Appraisal of life threat 
and treatment intensity 
.15 -.13 to 
.43 
.300  1.02 .87 to 
1.21 
.790 
Fear of Recurrence .60 .31 to 
.88  
.000  1.18 1.01 to 
1.37 
.038 
Appearance Concerns .16 -.02 to 
.34 
.074  1.04 .95 to 
1.14 
.403 
Quality of Life  -.08 -.16 to 
.01 
.086  .97 .93 to 
1.01 
.128 
  Abbreviations: B, Beta Coefficient; PCL-C, Post-Traumatic Stress Disorder Checklist – 
Civilian Version; PTSD, Post-Traumatic Stress Disorder; CI, Confidence Intervals 


























Statistic p value 
PCL Mean Score (SD) 
 
28.6 (10.4) 27.8 (12.5) t(38) = .35 .731 
Symptomatic in 3 Symptom Clusters 
 
6 (15.4) 5 (12.8) ---* 1 
Symptomatic in 2 Symptom Clusters 
 
6 (15.4) 4 (10.3) ---* .754 
Symptomatic in 1 Symptom Cluster 
 
7 (17.9) 6 (15.4) ---* 1 
Non-symptomatic 
 
20 (51.3) 24 (61.5)   
Met Cluster B (intrusion) 
criteria 
14 (35.9) 13 (33.3) ---* 1 
Met Cluster C (avoidance) 
criteria 
10 (25.6) 5 (12.8) ---* .180 
Met Cluster D (hyperarousal) 
criteria 
13 (33.3) 11 (28.2) ---* .791 
 







Fig 1 Consort diagram for study participants 
